Search Result "liposolubility"
Diet After Cholecystectomy
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 19 Year: 2019 Page: 3662-3665
Author(s): Donato F. Altomare,Maria T. Rotelli,Nicola Palasciano
Stimuli-responsive Drug Delivery Nanocarriers in the Treatment of Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 15 Year: 2020 Page: 2494-2513
Author(s): João A. Oshiro-Júnior,Camila Rodero,Gilmar Hanck-Silva,Mariana R. Sato,Renata Carolina Alves,Josimar O. Eloy,Marlus Chorilli
Nanoparticles in the Treatment of Mental Disorders: A New Tool in the Psychiatric Medication
Journal: Current Topics in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 282-286
Author(s): Eduardo Sobarzo-Sánchez,Seyed Mohammad Nabavi,Eugenio Uriarte,Lourdes Santana
Bile Acids in Physiology, Pathology and Pharmacology
Journal: Current Drug Metabolism
Volume: 17 Issue: 1 Year: 2016 Page: 4-29
Author(s): Jose J.G. Marin,Rocio I.R. Macias,Oscar Briz,Jesus M. Banales,Maria J. Monte
Dihydrotanshinone I Inhibits Pancreatic Cancer Progression via Hedgehog/Gli Signal Pathway
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 9 Year: 2023 Page: 731-741
Author(s):
Scutellaria baicalensis Extract-phospholipid Complex: Preparation and InitialPharmacodynamics Research in Rats
Journal: Current Pharmaceutical Biotechnology
Volume: 23 Issue: 6 Year: 2022 Page: 847-860
Author(s): Shibin Chen,Qiujie Xie,Ming Yang,Yajun Shi,Junhui Shi,Xiaobin Zeng
Understanding Promising Anticancer Targets for Heterocyclic Leads: An Introduction
Ebook: Key Heterocyclic Cores for Smart Anticancer DrugâDesign Part II
Volume: 2 Year: 2022
Author(s):
Doi: 10.2174/9789815040043122020004
Design, Synthesis, and Anti-Breast Cancer Activity of Novel Fluorinated7-O-Modified Genistein Derivatives
Journal: Medicinal Chemistry
Volume: 19 Issue: 1 Year: 2023 Page: 64-74
Author(s):
Progress in Nitrogen and Oxygen-based Heterocyclic Compounds for their Anticancer Activity: An Updates (2017-2020)
Ebook: Key Heterocyclic Cores for Smart Anticancer DrugâDesign Part I
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815040074122010009
Benfotiamine Reduces Dendritic Cell Inflammatory Potency
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 7 Year: 2021 Page: 1344-1351
Author(s): Neda Djedovic,Iva BožiÄ,ÄorÄe MiljkoviÄ,Irena Lavrnja